SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-033902
Filing Date
2024-02-13
Accepted
2024-02-13 16:58:29
Documents
2
Group Members
GREGG R. LEMKAUMSD CREDIT OPPORTUNITY MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d631111dsc13ga.htm SC 13G/A 85215
2 EX-99.1 d631111dex991.htm EX-99.1 7286
  Complete submission text file 0001193125-24-033902.txt   94452
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79364 | Film No.: 24627299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 (212) 303-1650
MSD Partners, L.P. (Filed by) CIK: 0001514334 (see all company filings)

IRS No.: 271522220 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A